104 related articles for article (PubMed ID: 34010031)
1. Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.
Cramer-van der Welle CM; Kastelijn EA; Plouvier BC; van Uden-Kraan CF; Schramel FMNH; Groen HJM; van de Garde EMW
JCO Clin Cancer Inform; 2021 May; 5():570-578. PubMed ID: 34010031
[TBL] [Abstract][Full Text] [Related]
2. Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
Cotarla I; Boron ML; Cullen SL; Spinner DS; Faulkner EC; Carroll MC; Shah S; Yagui-Beltran A
JCO Oncol Pract; 2020 Oct; 16(10):e1232-e1242. PubMed ID: 32552457
[TBL] [Abstract][Full Text] [Related]
3. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
[TBL] [Abstract][Full Text] [Related]
4. Digital Monitoring and Management of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Treated With Cancer Immunotherapy and Its Impact on Quality of Clinical Care: Interview and Survey Study Among Health Care Professionals and Patients.
Schmalz O; Jacob C; Ammann J; Liss B; Iivanainen S; Kammermann M; Koivunen J; Klein A; Popescu RA
J Med Internet Res; 2020 Dec; 22(12):e18655. PubMed ID: 33346738
[TBL] [Abstract][Full Text] [Related]
5. Cost and Survival Analysis Before and After Implementation of Dana-Farber Clinical Pathways for Patients With Stage IV Non-Small-Cell Lung Cancer.
Jackman DM; Zhang Y; Dalby C; Nguyen T; Nagle J; Lydon CA; Rabin MS; McNiff KK; Fraile B; Jacobson JO
J Oncol Pract; 2017 Apr; 13(4):e346-e352. PubMed ID: 28260402
[TBL] [Abstract][Full Text] [Related]
6. Palliative Care Referrals for Advanced Non-small-cell Lung Cancer (NSCLC): Patient and Provider Attitudes and Practices.
Feld E; Singhi EK; Phillips S; Huang LC; Shyr Y; Horn L
Clin Lung Cancer; 2019 May; 20(3):e291-e298. PubMed ID: 30862422
[TBL] [Abstract][Full Text] [Related]
7. Geriatric Assessment for Older Patients with Non-small Cell Lung Cancer: Daily Practice of Centers Participating in the NVALT25-ELDAPT Trial.
Driessen EJM; van Loon JGM; Maas HA; Dingemans AC; Janssen-Heijnen MLG
Lung; 2018 Aug; 196(4):463-468. PubMed ID: 29651598
[TBL] [Abstract][Full Text] [Related]
8. Palliative care units in lung cancer in the real-world setting: a single institution's experience and its implications.
Masel EK; Schur S; Nemecek R; Mayrhofer M; Huber P; Adamidis F; Maehr B; Unseld M; Watzke HH; Pirker R
Ann Palliat Med; 2017 Jan; 6(1):6-13. PubMed ID: 27701880
[TBL] [Abstract][Full Text] [Related]
9. Needs with Regard to Decision Support Systems for Treating Patients with Incurable Non-small Cell Lung Cancer.
Révész D; Engelhardt EG; Tamminga JJ; Schramel FMNH; Onwuteaka-Philipsen BD; van de Garde EMW; Steyerberg EW; de Vet HCW; Coupé VMH
J Cancer Educ; 2020 Apr; 35(2):345-351. PubMed ID: 30685832
[TBL] [Abstract][Full Text] [Related]
10. The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial.
Siegle A; Villalobos M; Bossert J; Krug K; Hagelskamp L; Krisam J; Handtke V; Deis N; Jünger J; Wensing M; Thomas M
Trials; 2018 Aug; 19(1):438. PubMed ID: 30107809
[TBL] [Abstract][Full Text] [Related]
11. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
12. Realizing better doctor-patient dialogue about choices in palliative care and early phase clinical trial participation: towards an online value clarification tool (OnVaCT).
van Lent LGG; Stoel NK; van Weert JCM; van Gurp J; de Jonge MJA; Lolkema MP; Gort EH; Pulleman SM; Oomen-de Hoop E; Hasselaar J; van der Rijt CCD
BMC Palliat Care; 2019 Nov; 18(1):106. PubMed ID: 31783851
[TBL] [Abstract][Full Text] [Related]
13. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
15. What Is Important When Making Treatment Decisions in Metastatic Breast Cancer? A Qualitative Analysis of Decision-Making in Patients and Oncologists.
Rocque GB; Rasool A; Williams BR; Wallace AS; Niranjan SJ; Halilova KI; Turkman YE; Ingram SA; Williams CP; Forero-Torres A; Smith T; Bhatia S; Knight SJ
Oncologist; 2019 Oct; 24(10):1313-1321. PubMed ID: 30872466
[TBL] [Abstract][Full Text] [Related]
16. Analyzing the effect of physician assignment in the survival of patients with advanced non-small-cell lung cancer.
Wheatley-Price P; Jonker H; Al-Baimani K; Mhang T; Nicholas G; Goss G; Laurie SA
Curr Oncol; 2020 Feb; 27(1):34-38. PubMed ID: 32218658
[TBL] [Abstract][Full Text] [Related]
17. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
[TBL] [Abstract][Full Text] [Related]
19. Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer.
Jennens RR; de Boer R; Irving L; Ball DL; Rosenthal MA
Chest; 2004 Dec; 126(6):1985-93. PubMed ID: 15596703
[TBL] [Abstract][Full Text] [Related]
20. Ten-year patient journey of stage III non-small cell lung cancer patients: A single-center, observational, retrospective study in Korea (Realtime autOmatically updated data warehOuse in healTh care; UNIVERSE-ROOT study).
Jung HA; Sun JM; Lee SH; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2020 Aug; 146():112-119. PubMed ID: 32526601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
